The global wearable medical devices for chronic disease management market has evolved from a supplementary monitoring segment into an integral component of long-term care delivery, driven by rising chronic disease prevalence, advances in medical-grade sensor technologies, and decentralised care models.
Excerpt
Executive Summary
The global wearable medical devices for chronic disease management market has evolved from a supplementary monitoring segment into an integral component of long-term care delivery. Growth is being shaped by increasing chronic disease prevalence, improvements in medical-grade sensor technologies, and the gradual decentralisation of healthcare delivery models. In 2024, the global market is estimated at US$42.0–45.0 billion, having grown at a compound annual growth rate of approximately 14.5 percent between 2019 and 2024. Based on current adoption trajectories and policy continuity assumptions, the market is projected to reach US$90.0–95.0 billion by 2030, representing a forecast compound annual growth rate of 13.2–13.8 percent.
For further context and detailed analysis, Contact Us.
--- Market Overview Context and Genesis of the Market
Wearable medical devices were initially introduced as episodic diagnostic and tracking tools, primarily for cardiac rhythm monitoring and glucose measurement. Over the past decade, advancements in biosensors, connectivity, and software platforms have repositioned these devices as continuous disease management systems. The shift from hospital-centric care to home-based and ambulatory models accelerated following the COVID-19 pandemic, which increased clinical acceptance of remote monitoring and digital care pathways.
Chronic diseases ac…